🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Vendors market the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users administering products of unknown origin.

Several experts said the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and consumer regulations, risking fines, legal action or prison.

Platform Response and Content Removal

Based on the social media company, the service has removed violative content and banned associated hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.

Within moments of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Product Details and Costs

Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how much time a injector should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already seen individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.